Menu

Speed Gene Traced to One Founder

Researchers track a racehorse “speed gene” back to a single mare in the United Kingdom.

Jan 26, 2012
Edyta Zielinska

FLICKR, MNSC

A gene linked to speed in today’s Thoroughbred horses was tracked back to a British mare that lived roughly 300 years ago, according to a study published in Nature Communications Tuesday (January 24).

The gene, a variant of myostatin, which is key in developing muscle mass in many species, was shown to predict the speed and stamina of a horse. Two copies of the C-type variant, for example, is likely to result in a horse that runs fast over short distances, ideal for the sprint races that are commonly run today. The other variant, the type T, is better suited for stamina, allowing horses to run fast for long distances.

Researchers looked at the genetics and pedigree of 593 horses, dead and alive, and tracked the C-type variant to a single mare. While horses carrying the C-type variant were still rare in the 18th and 19th centuries, they were widely propagated in the 1950s, ’60s, and ’70s by breeding two celebrated father-son stallions, Nearctic and Northern Dancer.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.